Latest News & Research from City of Hope
Lung cancer is not unbeatable. Each day, doctors and researchers in City of Hope’s Lung Cancer and Thoracic Oncology Program aggressively pursue innovative approaches to bring new treatments and cures to patients with all forms of this devastating disease.
   
 
As cancer care advances, allowing patients to recover from surgeries at home and receive the bulk of their care on an outpatient basis, the primary caregivers aren’t doctors or nurses. They’re family members.
   
Lung cancer incidence and deaths have declined in recent years — due to declining tobacco consumption — but lung cancer remains the second most commonly occurring cancer and the leading cause of cancer deaths in the United States.
   
Karen Reckamp, M.D., co-director of City of Hope’s Lung Cancer and Thoracic Oncology Program, sorts out facts about lung cancer and smoking, what current treatments are available, and simple ways to reduce lung cancer risk.
   
 
The U.S. Preventive Services Task Force  proposed annual screening, using low-dose CT scans, for people at high risk for lung cancer.
   
 
Study shows silibinin, an extract of the milk thistle plant, reverses drug resistance in small cell lung cancer.
   
 
Dan Raz, M.D., co-director of City of Hope’s Lung Cancer and Thoracic Oncology Program, discusses the benefits of screening for lung cancer and who can qualify.